Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination vaccines: postlicensure safety evaluation.

R T Chen1, V Pool, H Takahashi

  • 1Vaccine Safety and Development Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. bchen@cdc.gov

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HKD-MGIN: a physics informed graph neural network using heat kernel diffusion for mapping adolescent functional brain connectivity.

Machine learning for computational science and engineering·2026
Same author

Corrigendum to "Healthcare-worker-associated outbreak of Panton-Valentine-leukocidin-producing meticillin-sensitive Staphylococcus aureus in a large neonatal unit in London: successful targeted suppression therapy following failure of mass suppression therapy" [J Hosp Infect 122 (2022) 148-156].

The Journal of hospital infection·2025
Same author

Grading systems for tracheal intubation using videolaryngoscopy.

BJA education·2025
Same author

NHS tie-in impact on dental profession.

British dental journal·2025
Same author

Implementing Transitional Care Interventions for Surgical Patients: A Scoping Review.

Journal of advanced nursing·2025
Same author

Does A Dietitian-Led Celiac Disease Clinic (DLCC) Facilitate Timely Diagnosis and Nutrition Care for Patients With Celiac Disease?

Journal of gastroenterology and hepatology·2025

Investing in robust vaccine safety infrastructure is crucial for public confidence. Postlicensure studies and enhanced monitoring systems are key to addressing vaccine risks and ensuring immunization safety.

Area of Science:

  • Public Health
  • Immunology
  • Pharmacovigilance

Background:

  • Vaccine-preventable diseases have significantly decreased due to successful immunization programs.
  • Limitations in prelicensure vaccine safety trials necessitate robust postlicensure safety surveillance.
  • Public trust in vaccines requires ongoing assessment of potential risks, including those from combination vaccines.

Purpose of the Study:

  • To review and recommend measures for enhancing postlicensure vaccine safety monitoring.
  • To address the growing need for studying vaccine risks in the context of widespread immunization.
  • To ensure public confidence in vaccine safety through improved infrastructure and methodologies.

Main Methods:

  • Establishment of clinical immunization safety assessment centers.

Related Experiment Videos

  • Standardization of case definitions for adverse events following immunization (AEFI).
  • Utilization of the Vaccine Identification Standards Initiative (VISI) for improved data transfer.
  • Integration of vaccine safety monitoring within immunization registries.
  • Expansion of the Vaccine Safety Datalink (VSD) project.
  • Application of innovative analytical tools for enhanced signal detection.
  • Implementation of methods to mitigate confounding by contraindication.

    • Main Results:

    • The article outlines a comprehensive set of strategies to strengthen vaccine safety infrastructure.
    • These measures aim to improve the accuracy, efficiency, and scope of postlicensure vaccine safety studies.
    • The proposed infrastructure enhancements are designed to build public confidence in immunization.

    Conclusions:

    • Significant investment in vaccine safety infrastructure, comparable to vaccine development, is essential.
    • Enhanced postlicensure surveillance and data analysis are critical for maintaining public trust in vaccines.
    • A proactive approach to vaccine safety is necessary to sustain high immunization rates and public confidence.